Skip to content

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06936670
Acronym
IMST
Enrollment
90
Registered
2025-04-20
Start date
2025-04-30
Completion date
2026-02-28
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2

Keywords

Type 2 Diabetes, Inspiratory Strength Training, Blood Pressure, Kidney Health, Cardiovascular Function, Diabetic Kidney Disease

Brief summary

High-resistance, short-duration inspiratory muscle strength training (IMST) is a novel lifestyle intervention involving 30 inhalations against a resistive load which requires only \ 5 min/day and is thus ideal for youth with T2D (Y-T2D). Investigators seek to 1: assess changes in casual and 24-hr SBP, endothelial function, and arterial stiffness after 3 months of IMST vs. sham training in Y-T2D, 2: Define changes in eGFR andalbuminuria after 3 months of IMST vs. sham in Y-T2D, 3: Interrogate mechanisms of IMST by translational assessments of NO bioavailability, endothelial NO synthase (eNOS) activation, and ROS/oxidative stress, and determine the role of circulating factors.

Interventions

A novel form of physical training that uses the diaphragm and accessory respiratory muscles to repeatedly inhale against resistance using a handheld device, generating large negative intrathoracic pressures. The device can be set to different levels of resistance, meaning the intervention and sham groups will undergo the same training, but at 75% and 15% of their maximal inspiratory pressure respectively.

DEVICESham Training

The same training regiment but at much lower resistance, offering little to strength training impact.

Sponsors

University of Washington
CollaboratorOTHER
Seattle Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
14 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

Aged 14-40, have had T2D for a least one year, HbA1C less than 12%. \-

Exclusion criteria

Have had type II diabetes for more than 18 years, estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m2 or Albumin-to-creatinine ratio (ACR) greater than 2200mg/g, blood pressure greater than 160/100 mm Hg. \-

Design outcomes

Primary

MeasureTime frameDescription
Systolic Blood Pressure3 monthsMeasures of casual clinic and 24-hour ambulatory blood pressure monitoring

Secondary

MeasureTime frameDescription
Endothelial function3 monthsMeasured by brachial artery flow-mediated dilation and endothelial cell collection and analysis.
Arterial stiffness3 monthsMeasured by carotid-femoral pulse-wave velocity and carotid-radial pulse-wave analysis using a SphygmoCor.
Kidney Function3 monthsMeasured by estimated glomerular filtration rate and albuminuria assessments
Body Composition3 monthsMeasured by BIS (Bioimpedance spectroscopy)

Countries

United States

Contacts

Primary ContactKalie Tommerdahl, MD
ktomme@uw.edu(206) 616-9015

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026